Bioadhesive tablet for non-systemic use products

Claim 2

A bioadhesive controlled-release solid tablet, comprising a controlled release bioadhesive excipient comprising a heterodisperse gum matrix comprising a heteropolysaccharide gum and a homopolysaccharide gum capable of cross-linking said heteropolysaccharide gum in the presence of aqueous solutions, the ratio of said heteropolysaccharide gum to said homopolysaccharide gum being from about 1:3 to about 3:1; an inert pharmaceutical diluent selected from the group consisting of monosaccharide, a disaccharide, a polyhydric alcohol, and mixtures thereof, the ratio of said inert diluent to said heterodisperse gum matrix being from about 21:1 to 200:1; and a locally active agent in an amount effective to render a local effect when the formulation is exposed to fluid in an environment of use.

Claim 3

The tablet of claim 1, wherein said a heteropolysaccharide gum comprises xanthan gum and said homopolysaccharide gum comprises locust bean gum.

Claim 4

The tablet of claim 1, wherein said locally active agent is selected from the group consisting of analgesics, anti-inflammatory agents, anti-tussive agents, hormones, antibiotics, antacids, anti-plaque agents, anticariogenic agents, oral antiseptics, breath fresheners, local anesthetics, tooth desensitizers, antifungal agents, acidity reducing agents, anti-viral agents and mixtures of the foregoing.

Claim 5

The tablet of claim 1 which further comprises from about 1 to about 10 percent by weight of an additional bioadhesive agent selected from the group consisting of carbomer, poly carbophil, poly oxyethylene oxide, and mixtures of any of the foregoing.

Claim 6

The tablet of claim 1, wherein the ratio of inert diluent to heterodisperse gum matrix is from about 21:1 to about 100:1.

Claim 7

The tablet of claim 1, which comprises from about 0.1 to about 20 percent of said additional bioadhesive agent by weight.

Claim 8

A controlled release bioadhesive tablet for administration in the oral cavity, comprising (i) a heterodisperse gum matrix comprising xanthan and locust bean gum in a ratio of about 1:1; (ii) an inert pharmaceutically acceptable diluent selected from the group consisting of a monosaccharide, a disaccharide, and mixtures thereof, the ratio of said diluent to said heterodisperse gum matrix being from about 21:1 to about 200:1; and (iii) an effective amount of a active agent to render a localized effect in the oral cavity, said heterodisperse gum matrix being in an amount effective to adhere to the oral mucosa while providing a controlled release of said active agent in the oral cavity when exposed to saliva.

Claim 9

A controlled release bioadhesive tablet for administration in the oral cavity, comprising (i) a heterodisperse gum matrix comprising xanthan and locust bean gum in a ratio of about 1:1; (ii) an inert pharmaceutically acceptable diluent selected from the group consisting of a monosaccharide, a disaccharide, and mixtures thereof, the ratio of said diluent to said heterodisperse gum matrix being from about 21:1 to about 200:1; and (iii) an effective amount of a active agent to render a localized effect in the oral cavity, said heterodisperse gum matrix being in an amount effective to adhere to the oral mucosa while providing a controlled release of said active agent in the oral cavity when exposed to saliva.

Claim 10

The tablet of claim 7, which further comprises from about 1 to about 20 percent by weight of an additional bioadhesive agent selected from the group consisting of carbomer, poly carbophil, poly oxyethlyene oxide, and mixtures of any of the foregoing.

Claim 11

The solid dosage form of claim 7, wherein said locally active agent is selected from the group consisting of analgesics, anti-inflammatory agents, anti-tussive agents, hormones, anti-biotics, antacids, anti-plaque agents, anticariogenic agents, oral antiseptics, breath fresheners, local anesthetics, tooth desensitizers, antifungal agents, acidity reducing agents, anti-viral agents and mixtures of the foregoing.

Claim 12

A controlled release bioadhesive excipient, comprising a heterodisperse gum matrix comprising a heteropolysaccharide gum having bioadhesive properties and a homopolysaccharide gum capable of cross-linking said heteropolysaccharide gum in the presence of aqueous solutions, the ratio of said heteropolysaccharide gum to said homopolysaccharide gum being from about 1:3 to about 3:1; a bioadhesive agent selected from the group consisting of carbomer, poly carbophil, poly oxyethylene oxide, and mixtures of any of the foregoing, said bioadhesive agent being in an amount sufficient, in combination with said heterodisperse gum, to provide said excipient with a desired bioadhesive effect; and an inert pharmaceutical diluent selected from the group consisting of monosaccharide, a disaccharide, a polyhydric alcohol, and mixtures thereof.

Claim 13

A controlled release bioadhesive excipient, comprising a heterodisperse gum matrix comprising a heteropolysaccharide gum having bioadhesive properties and a homopolysaccharide gum capable of cross-linking said heteropolysaccharide gum in the presence of aqueous solutions, the ratio of said heteropolysaccharide gum to said homopolysaccharide gum being from about 1:3 to about 3:1; a bioadhesive agent selected from the group consisting of carbomer, poly carbophil, poly oxyethylene oxide, and mixtures of any of the foregoing, said bioadhesive agent being in an amount sufficient, in combination with said heterodisperse gum, to provide said excipient with a desired bioadhesive effect; and an inert pharmaceutical diluent selected from the group consisting of monosaccharide, a disaccharide, a polyhydric alcohol, and mixtures thereof.

Claim 14

The excipient of claim 10, wherein said a heteropolysaccharide gum comprises xanthan gum and said homopolysaccharide gum comprises locust bean gum.

Claim 15

The controlled release bioadhesive excipient of claim 10, which comprises from about 10 to about 50 percent by weight heterodisperse gum matrix, from about 10 to about 50 percent by weight bioadhesive agent, and from about 40 to about 80 percent inert diluent.

Claim 16

The controlled release excipient of claim 12, which comprises from about 10 to about 30 percent by weight heterodisperse gum matrix, from about 10 to about 30 percent by weight bioadhesive agent, and from about 40 to about 80 percent inert diluent.